Ultrasight and Korea-based Selvas Healthcare have entered a partnership to develop and commercialize AI-powered cardiac ultrasound software in Asia.
The new joint venture creates a pathway for introducing UltraSight’s technology to Korean market, the company said.
UltraSight’s software pairs with point-of-care ultrasound (POCUS) devices to provide medical professionals with real-time guidance to acquire diagnostic-quality cardiac ultrasound images. Selvas will have exclusive rights to distribute and commercialize UltraSight’s AI cardiac ultrasound technology in Korea, UltraSight noted.
